1i85: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
Regulation of T-cell activity is dependent on antigen-independent, co-stimulatory signals provided by the disulphide-linked homodimeric, T-cell surface receptors, CD28 and CTLA-4 (ref. 1). Engagement of CD28, with B7-1 and B7-2 ligands on antigen-presenting cells (APCs) provides a, stimulatory signal for T-cell activation, whereas subsequent engagement of, CTLA-4 with these same ligands results in attenuation of the response., Given their central function in immune modulation, CTLA-4- and, CD28-associated signalling pathways are primary therapeutic targets for, preventing autoimmune disease, graft versus host disease, graft rejection, and promoting tumour immunity. However, little is known about the, cell-surface organization of these receptor/ligand complexes and the, structural basis for signal transduction. Here we report the 3.2-A, resolution structure of the complex between the disulphide-linked, homodimer of human CTLA-4 and the receptor-binding domain of human B7-2., The unusual dimerization properties of both CTLA-4 and B7-2 place their, respective ligand-binding sites distal to the dimer interface in each, molecule and promote the formation of an alternating arrangement of, bivalent CTLA-4 and B7-2 dimers that extends throughout the crystal., Direct observation of this CTLA-4/B7-2 network provides a model for the, periodic organization of these molecules within the immunological synapse, and suggests a distinct mechanism for signalling by dimeric cell-surface, receptors.
Regulation of T-cell activity is dependent on antigen-independent co-stimulatory signals provided by the disulphide-linked homodimeric T-cell surface receptors, CD28 and CTLA-4 (ref. 1). Engagement of CD28 with B7-1 and B7-2 ligands on antigen-presenting cells (APCs) provides a stimulatory signal for T-cell activation, whereas subsequent engagement of CTLA-4 with these same ligands results in attenuation of the response. Given their central function in immune modulation, CTLA-4- and CD28-associated signalling pathways are primary therapeutic targets for preventing autoimmune disease, graft versus host disease, graft rejection and promoting tumour immunity. However, little is known about the cell-surface organization of these receptor/ligand complexes and the structural basis for signal transduction. Here we report the 3.2-A resolution structure of the complex between the disulphide-linked homodimer of human CTLA-4 and the receptor-binding domain of human B7-2. The unusual dimerization properties of both CTLA-4 and B7-2 place their respective ligand-binding sites distal to the dimer interface in each molecule and promote the formation of an alternating arrangement of bivalent CTLA-4 and B7-2 dimers that extends throughout the crystal. Direct observation of this CTLA-4/B7-2 network provides a model for the periodic organization of these molecules within the immunological synapse and suggests a distinct mechanism for signalling by dimeric cell-surface receptors.


==Disease==
==Disease==
Line 16: Line 16:
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Protein complex]]
[[Category: Protein complex]]
[[Category: Almo, S.C.]]
[[Category: Almo, S C.]]
[[Category: Fedorov, A.A.]]
[[Category: Fedorov, A A.]]
[[Category: Nathenson, S.G.]]
[[Category: Nathenson, S G.]]
[[Category: Schwartz, J.C.D.]]
[[Category: Schwartz, J C.D.]]
[[Category: Zhang, X.]]
[[Category: Zhang, X.]]
[[Category: ig v-type domain]]
[[Category: ig v-type domain]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 15:59:56 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 13:09:00 2008''